Radiation metabolomics. 2. dose- and time-dependent urinary excretion of deaminated purines and pyrimidines after sublethal gamma-radiation exposure in mice

Radiation Research

Volumn 172, Issue 1, 2009, Pages 42-57

  Tyburski, John B ^a   Patterson, Andrew D ^a   Krausz, Kristopher W ^a   Slavk, Josef ^b   Fornace Jr , Albert J ^c   Gonzalez, Frank J ^a   Idle, Jeffrey R ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF BERN   (Switzerland)

^c GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2' DEOXYXANTHOSINE; AMINOPYRIMIDINE 2' DEOXYCYTIDINE; BIOLOGICAL MARKER; DEOXYCYTIDINE; DEOXYURIDINE; PURINE; PURINE DERIVATIVE; PYRIMIDINE; PYRIMIDINE DERIVATIVE; THYMIDINE; UNCLASSIFIED DRUG; XANTHINE; XANTHOSINE; 2'-DEOXYXANTHOSINE; DEOXYRIBONUCLEOSIDE; RIBONUCLEOSIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GAMMA RADIATION; LIQUID CHROMATOGRAPHY; METABOLOME; METABOLOMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; TANDEM MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY; URINARY EXCRETION; ANALYSIS OF VARIANCE; ANIMAL; C57BL MOUSE; DEAMINATION; MALE; METABOLISM; MULTIVARIATE ANALYSIS; RADIATION RESPONSE; TIME; URINE;

MUS;

ANALYSIS OF VARIANCE; ANIMALS; BIOLOGICAL MARKERS; DEAMINATION; DEOXYRIBONUCLEOSIDES; DEOXYURIDINE; DOSE-RESPONSE RELATIONSHIP, RADIATION; GAMMA RAYS; MALE; MICE; MICE, INBRED C57BL; MULTIVARIATE ANALYSIS; PURINES; PYRIMIDINES; RIBONUCLEOSIDES; TANDEM MASS SPECTROMETRY; THYMIDINE; TIME FACTORS; XANTHINE;

EID: 67949095917     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR1703.1     Document Type: Article

References (42)

1. E. J. Hall and A. J. Giaccia, Radiobiology for the Radiologist, 6th ed. Lippincott Williams & Wilkins, Philadelphia, 2006.
2. N. J. Chao, Accidental or intentional exposure to ionizing radiation: biodosimetry and treatment options. Exp. Hematol. 35, 24-27 (2007).
3. T. C. Pellmar and S. Rockwell, Priority list of research areas for radiological nuclear threat countermeasures. Radiat. Res. 163, 115-123 (2005).
4. J. B. Tyburski, A. D. Patterson, K. W. Krausz, J. Slavik, A. J. Fornace, Jr., F. J. Gonzalez and J. R. Idle, Radiation metabolomics. 1. Identification of minimally invasive urine biomarkers for gamma-radiation exposure in mice. Radiat. Res. 170, 1-14 (2008).
5. O. Fiehn, Metabolomics - the link between genotypes and phenotypes. Plant Mol. Biol. 48, 155-171 (2002).
6. E. Zerhouni, Medicine. The NIH Roadmap. Science 302, 63-72 (2003).
7. Y. Zhen, O. Slanar, K. W. Krausz, C. Chen, J. Slavik, K. L. McPhail, T. M. Zabriskie, F. Perlik, F. J. Gonzalez and J. R. Idle, 3,4-Dehydrodebrisoquine, a novel debrisoquine metabolite formed from 4-hydroxydebrisoquine that affects the CYP2D6 metabolic ratio. Drug Metab. Dispos. 34, 1563-1574 (2006).
8. S. Giri, K. W. Krausz, J. R. Idle and F. J. Gonzalez, The metabolomics of (+/-)-arecoline 1-oxide in the mouse and its formation by human flavin-containing monooxygenases. Biochem. Pharmacol. 73, 561-573 (2007).
9. Y. Zhen, K. W. Krausz, C. Chen, J. R. Idle and F. J. Gonzalez, Metabolomic and genetic analysis of biomarkers for peroxisome proliferator-activated receptor alpha expression and activation. Mol. Endocrinol. 21, 2136-2151 (2007).
10. M. S. Sabatine, E. Liu, D. A. Morrow, E. Heller, R. McCarroll, R. Wiegand, G. F. Berriz, F. P. Roth and R. E. Gerszten, Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation 112, 3868-3875 (2005).
11. J. Castro-Perez, R. Plumb, J. H. Granger, I. Beattie, K. Joncour and A. Wright, Increasing throughput and information content for in vitro drug metabolism experiments using ultra-performance liquid chromatography coupled to a quadrupole time-of-flight mass spectrometer. Rapid Commun. Mass Spectrom. 19, 843-848 (2005).
12. R. Plumb, J. Castro-Perez, J. Granger, I. Beattie, K. Joncour and A. Wright, Ultra-performance liquid chromatography coupled to quadrupole-orthogonal time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 18, 2331-2337 (2004).
13. S. R. Dunn, Z. Qi, E. P. Bottinger, M. D. Breyer and K. Sharma, Utility of endogenous creatinine clearance as a measure of renal function in mice. Kidney Int. 65, 1959-1967 (2004).
14. N. Takahashi, G. Boysen, F. Li, Y. Li and J. A. Swenberg, Tandem mass spectrometry measurements of creatinine in mouse plasma and urine for determining glomerular filtration rate. Kidney Int. 71, 266-271 (2007).
15. I. Noda, Scaling techniques to enhance two-dimensional correlation spectra. J. Mol. Struct. 883-884, 216-227 (2008).
16. K. Pearson, On lines and planes of closest fit to systems of points in space. Philos. Mag. 2, 559-572 (1901).
17. J. Trygg and S. Wold, Orthogonal projections to latent structures (O-PLS). J. Chemometrics 16, 119-128 (2002).
18. H. Hotelling, The generalization of Student's ratio. Ann. Math. Stat. 2, 360-378 (1931).
19. B. Rosner, Fundamentals of Biostatistics, 5th ed. Duxbury, Pacific Grove, CA, 2000.
20. Q. Cui, I. A. Lewis, A. D. Hegeman, M. E. Anderson, J. Li, C. F. Schulte, W. M. Westler, H. R. Eghbalnia, M. R. Sussman and J. L. Markley, Metabolite identification via the Madison Metabolomics Consortium Database. Nat. Biotechnol. 26, 162-164 (2008).
21. A. J. Williams, Internet-based tools for communication and collaboration in chemistry. Drug Discov. Today 13, 502-506 (2008).
22. A. J. Williams, Public chemical compound databases. Curr. Opin. Drug Discov. Dev. 11, 393-404 (2008).
23. L. Breiman, Random forests. Machine Learning 45, 5-32 (2001).
24. B. L. Browning, PRESTO: rapid calculation of order statistic distributions and multiple-testing adjusted P-values via permutation for one and two-stage genetic association studies. BMC Bioinformat. 9, 309 (2008).
25. S. Wiklund, E. Johansson, L. Sjostrom, E. J. Mellerowicz, U. Edlund, J. P. Shockcor, J. Gottfries, T. Moritz and J. Trygg, Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. Anal. Chem. 80, 115-122 (2008).
26. T. S. Chan, B. D. Lakhchaura and T. F. Hsu, Differences in deoxycytidine metabolism in mouse and rat. Biochem. J. 210, 367-371 (1983).
27. V. Batra, V. Kesavan and K. P. Mishra, Modulation of enzymes involved in folate dependent one-carbon metabolism by gamma-radiation stress in mice. J. Radiat. Res. (Tokyo) 45, 527-533 (2004).
28. K. Taghizadeh, J. L. McFaline, B. Pang, M. Sullivan, M. Dong, E. Plummer and P. C. Dedon, Quantification of DNA damage products resulting from deamination, oxidation and reaction with products of lipid peroxidation by liquid chromatography isotope dilution tandem mass spectrometry. Nat. Protoc. 3, 1287-1298 (2008).
29. B. Pang, X. Zhou, H. Yu, M. Dong, K. Taghizadeh, J. S. Wishnok, S. R. Tannenbaum and P. C. Dedon, Lipid peroxidation dominates the chemistry of DNA adduct formation in a mouse model of inflammation. Carcinogenesis 28, 1807-1813 (2007).
30. R. S. Plumb, J. H. Granger, C. L. Stumpf, K. A. Johnson, B. W. Smith, S. Gaulitz, I. D. Wilson and J. Castro-Perez, A rapid screening approach to metabonomics using UPLC and oa-TOF mass spectrometry: application to age, gender and diurnal variation in normal/Zucker obese rats and black, white and nude mice. Analyst 130, 844-849 (2005).
31. C. M. Slupsky, K. N. Rankin, J. Wagner, H. Fu, D. Chang, A. M. Weljie, E. J. Saude, B. Lix, D. J. Adamko and T. J. Marrie, Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles. Anal. Chem. 79, 6995-7004 (2007).
32. S. Ohta, S. Matsuda, M. Gunji and A. Kamogawa, The role of nitric oxide in radiation damage. Biol. Pharm. Bull. 30, 1102-1107 (2007).
33. N. V. Voevodskaya and A. F. Vanin, Gamma-irradiation potentiates L-arginine-dependent nitric oxide formation in mice. Biochem. Biophys. Res. Commun. 186, 1423-1428 (1992).
34. A. Agrawal, D. Chandra and R. K. Kale, Radiation induced oxidative stress: II Studies in liver as a distant organ of tumor bearing mice. Mol. Cell Biochem. 224, 9-17 (2001).
35. M. S. Baliga, G. C. Jagetia, P. Venkatesh, R. Reddy and J. N. Ulloor, Radioprotective effect of abana, a polyherbal drug following total body irradiation. Br. J. Radiol. 77, 1027-1035 (2004).
36. M. S. Uspenskaia and E. V. Rabinkova, [The excretion of thymidine in the urine in Sr90-injured rats]. Med. Radiol. (Mosk.) 10, 19-22 (1965).
37. A. Zharkov Iu, T. A. Fedorova and L. F. Mikhailova, [The excretion of thymidine in the urine of rats after total body x-ray irradiation in various doses]. Radiobiologiia 5, 675-680 (1965).
38. V. K. Mazurik, L. E. Bryksina, D. B. Saprygin and A. A. Iarilin, [A study of the role of lymphoid tissue in post-radiation hyperexcretion of deoxycytidine, deoxyuridine and thymidine by use of specific antisera]. Radiobiologiia 10, 346-349 (1970).
39. V. K. Mazurik, L. E. Bryksina and L. N. Bibikhin, [The relationship between the excretion of deoxyuridine, thymidine and beta-aminoisobutyric acid by rats and the radiation dose and length of time following total irradiation]. Radiobiologiia 10, 43-48 (1970).
40. S. Loft, A. Fischer-Nielsen, I. B. Jeding, K. Vistisen and H. E. Poulsen, 8-Hydroxydeoxyguanosine as a urinary biomarker of oxidative DNA damage. J. Toxicol. Environ. Health 40, 391-404 (1993).
41. R. Cathcart, E. Schwiers, R. L. Saul and B. N. Ames, Thymine glycol and thymidine glycol in human and rat urine: a possible assay for oxidative DNA damage. Proc. Natl. Acad. Sci. USA 81, 5633-5637 (1984).
42. B. Graham, J. Talent, G. Allison, R. Cleveland, S. Rade-maker, T. Roemer, W. Sherman, H. Sokolski and R. Verma, World at Risk. The Report of the Commission on the Prevention of WMD Proliferation and Terrorism. Vintage Books, New York, 2008.